Table 1.
The clinical characteristics of male patients with lung cancer
| Characteristics | OM group | NOM group | P value* | |
|---|---|---|---|---|
| (n=50) | (n=2188) | |||
| Age# | ||||
| Mean | 58.82±10.32 | 61.23±10.32 | 0.157 | |
| Smoking statue | ||||
| Ever/Current | 25(50.0%) | 483(22.1%) | <0.001 | |
| Never | 25(50.0%) | 1705(77.9%) | ||
| Histopathological type## | ||||
| Squamous cell carcinoma | 7(14.0%) | 970(44.3%) | <0.001 | |
| Adenocarcinoma | 34(68.0%) | 759(34.7%) | ||
| Large cell carcinoma | 0(0.0%) | 29(1.3%) | ||
| Small cell lung cancer (SCLC) | 5(10.0%) | 306(14.0%) | ||
| Other NSCLC | 0(0.0%) | 23(1.1%) | ||
| Unknown | 4(8.0%) | 101(4.6%) | ||
| Treatment | ||||
| Surgery | 7 | 555 | ||
| Chemotherapy | 28 | 986 | ||
| Radiotherapy | 12 | 130 | ||
| Symptomatic treatment | 3 | 403 | ||
| Others | 0 | 114 | ||
Notes: OM group included 16 orbital metastasis cases and 34 intraocular metastasis cases. #: Student-t test was used. ##: Chi-square test was used. *: comparison between OM group and NOM group. P<0.05 represented statistically significant.
Abbreviations: OM, ocular metastasis; NOM, non-ocular metastasis; NSCLC, non-small cell lung cancer.